- A new clinical trial in Italy investigates the efficacy of oral semaglutide.
- Semaglutide and other GLP-1 agonist drugs to treat diabetes, cardiovascular health, and weight loss, are most widely available as injectable medications.
- The study finds that oral versions of the drug perform best in patients in the early stages of diabetes, and not as well as injectables for other people.
- Even though doses of oral semaglutide are significantly larger than injectable medications, far less of it gets…
Read the full article here